Results of a survey indicate a positive response among patients to redesigned patient medication information distributed to patients at retail pharmacy chains in two states as part of an eight-week program.

A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.

Generic drug maker Sandoz has launched a generic version of a drug used to treat high blood pressure and angina.

The Food and Drug Administration has approved a new strength of an antibiotic made by Warner Chilcott, the drug maker said.

Does the Obama administration “get it” when it comes to pharmacy’s vital interests and lowering health care costs?

One sometimes wonders. As much as I like the president and many of his ideas and instincts, I’m sometimes stumped by some of the lesser-understood facets of the administration’s health policy, and by the seemingly contradictory sets of priorities promoted by that policy.

Johnson & Johnson's sales increased by 8.5% to $17.5 billion in first quarter 2013, the healthcare products company said Tuesday.

Sam's Club offered free oral care and health screening events at all 564 of its stores that have pharmacies, the club retailer said.

Generic makers heralded the fiscal year 2014 budget proposed last week by the Obama administration for its embrace of generic drugs, but were critical of its provisions on patent settlements and rebates.

The governor of North Dakota has signed into law a bill that would require pharmacy benefit managers to inform pharmacies about how reimbursement for generic prescription drugs is calculated under maximum allowable cost benchmarks and provide a more detailed appeals process to pharmacies to contest the MAC reimbursement caps that PBMs set up.

The University of Utah's College of Pharmacy has opened a new research organization designed to encourage collaboration and interaction, according to published reports.

The Food and Drug Administration is granting an expedited application process to a company that has developed a treatment for a condition related to Parkinson's disease, meaning that it can cancel a planned late-stage clinical trial, the company said.

Drug companies' pharmaceutical portfolio management teams spend most of their time and budgets supporting niche products, according to a new study.